Vir Biotechnology Inc (VIR)
9.72
-0.21
(-2.11%)
USD |
NASDAQ |
May 17, 16:00
9.72
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 164.63M |
| September 30, 2023 | 116.30M |
| June 30, 2023 | -487.35M |
| March 31, 2023 | -989.99M |
| December 31, 2022 | -1.193B |
| September 30, 2022 | -1.418B |
| June 30, 2022 | -681.44M |
| March 31, 2022 | -333.74M |
| December 31, 2021 | -140.81M |
| Date | Value |
|---|---|
| September 30, 2021 | 297.48M |
| June 30, 2021 | 38.24M |
| March 31, 2021 | -26.55M |
| December 31, 2020 | -9.862M |
| September 30, 2020 | -144.34M |
| June 30, 2020 | 88.33M |
| March 31, 2020 | 122.22M |
| December 31, 2019 | -256.16M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.418B
Minimum
Sep 2022
297.48M
Maximum
Sep 2021
-285.55M
Average
-140.81M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
| Vertex Pharmaceuticals Inc | -3.444B |
| SeaStar Medical Holding Corp | -- |
| NovaBay Pharmaceuticals Inc | 1.062M |
| Palatin Technologies Inc | 9.41M |
| iBio Inc | 8.285M |